Medical - Distribution
Compare Stocks
5 / 10Stock Comparison
PBH vs COTY vs CHD vs PRGO vs PG
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
Drug Manufacturers - Specialty & Generic
Household & Personal Products
PBH vs COTY vs CHD vs PRGO vs PG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Distribution | Household & Personal Products | Household & Personal Products | Drug Manufacturers - Specialty & Generic | Household & Personal Products |
| Market Cap | $2.49B | $2.17B | $22.12B | $1.62B | $342.14B |
| Revenue (TTM) | $1.10B | $5.79B | $6.21B | $4.18B | $86.72B |
| Net Income (TTM) | $187M | $-536M | $733M | $-1.82B | $12.72B |
| Gross Margin | 56.4% | 61.9% | 45.1% | 34.2% | 50.3% |
| Operating Margin | 29.2% | -0.3% | 17.3% | -4.1% | 23.2% |
| Forward P/E | 11.6x | 8.2x | 24.9x | 5.5x | 21.2x |
| Total Debt | $1.04B | $4.25B | $2.21B | $3.97B | $35.46B |
| Cash & Equiv. | $98M | $257M | $409M | $532M | $9.56B |
PBH vs COTY vs CHD vs PRGO vs PG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Prestige Consumer H… (PBH) | 100 | 124.5 | +24.5% |
| Coty Inc. (COTY) | 100 | 68.0 | -32.0% |
| Church & Dwight Co.… (CHD) | 100 | 124.4 | +24.4% |
| Perrigo Company plc (PRGO) | 100 | 21.4 | -78.6% |
| The Procter & Gambl… (PG) | 100 | 126.3 | +26.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PBH vs COTY vs CHD vs PRGO vs PG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PBH has the current edge in this matchup, primarily because of its strength in valuation efficiency.
- PEG 1.28 vs PG's 3.80
- Lower P/E (11.6x vs 21.2x), PEG 1.28 vs 3.80
- 16.9% margin vs PRGO's -43.5%
Among these 5 stocks, COTY doesn't own a clear edge in any measured category.
CHD is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
- Lower volatility, beta 0.15, Low D/E 55.1%, current ratio 1.07x
- 1.6% revenue growth vs COTY's -3.7%
- +2.6% vs PRGO's -52.0%
PRGO is the clearest fit if your priority is dividends.
- 9.8% yield, 10-year raise streak, vs PG's 2.7%, (1 stock pays no dividend)
PG ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.13, yield 2.7%
- 119.7% 10Y total return vs CHD's 112.6%
- Beta 0.13, yield 2.7%, current ratio 0.70x
- Beta 0.13 vs PRGO's 1.21, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.6% revenue growth vs COTY's -3.7% | |
| Value | Lower P/E (11.6x vs 21.2x), PEG 1.28 vs 3.80 | |
| Quality / Margins | 16.9% margin vs PRGO's -43.5% | |
| Stability / Safety | Beta 0.13 vs PRGO's 1.21, lower leverage | |
| Dividends | 9.8% yield, 10-year raise streak, vs PG's 2.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +2.6% vs PRGO's -52.0% | |
| Efficiency (ROA) | 10.0% ROA vs PRGO's -19.8%, ROIC 20.1% vs 3.7% |
PBH vs COTY vs CHD vs PRGO vs PG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PBH vs COTY vs CHD vs PRGO vs PG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PG leads in 2 of 6 categories
PBH leads 1 • COTY leads 1 • CHD leads 0 • PRGO leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PBH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 78.6x PBH's $1.1B. PBH is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $5.8B | $6.2B | $4.2B | $86.7B |
| EBITDAEarnings before interest/tax | $353M | $314M | $1.3B | $58M | $21.9B |
| Net IncomeAfter-tax profit | $187M | -$536M | $733M | -$1.8B | $12.7B |
| Free Cash FlowCash after capex | $267M | $311M | $1.1B | $108M | $15.0B |
| Gross MarginGross profit ÷ Revenue | +56.4% | +61.9% | +45.1% | +34.2% | +50.3% |
| Operating MarginEBIT ÷ Revenue | +29.2% | -0.3% | +17.3% | -4.1% | +23.2% |
| Net MarginNet income ÷ Revenue | +16.9% | -9.3% | +11.8% | -43.5% | +14.7% |
| FCF MarginFCF ÷ Revenue | +24.2% | +5.4% | +17.2% | +2.6% | +17.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | -1.3% | +0.1% | -7.2% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.5% | 0.0% | +2.2% | -56.4% | +5.8% |
Valuation Metrics
COTY leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 12.2x trailing earnings, PBH trades at a 60% valuation discount to CHD's 30.9x P/E. Adjusting for growth (PEG ratio), PBH offers better value at 1.35x vs PG's 4.02x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.5B | $2.2B | $22.1B | $1.6B | $342.1B |
| Enterprise ValueMkt cap + debt − cash | $3.4B | $6.2B | $23.9B | $5.1B | $368.1B |
| Trailing P/EPrice ÷ TTM EPS | 12.25x | -5.61x | 30.92x | -1.14x | 22.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.57x | 8.17x | 24.90x | 5.53x | 21.24x |
| PEG RatioP/E ÷ EPS growth rate | 1.35x | — | — | — | 4.02x |
| EV / EBITDAEnterprise value multiple | 9.35x | 9.32x | 18.05x | 7.43x | 15.80x |
| Price / SalesMarket cap ÷ Revenue | 2.19x | 0.37x | 3.57x | 0.38x | 4.06x |
| Price / BookPrice ÷ Book value/share | 1.43x | 0.54x | 5.70x | 0.55x | 6.87x |
| Price / FCFMarket cap ÷ FCF | 10.22x | 7.83x | 20.24x | 11.17x | 24.36x |
Profitability & Efficiency
PG leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PG delivers a 23.8% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-51 for PRGO. CHD carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), PBH scores 8/9 vs PRGO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.2% | -14.1% | +17.4% | -50.7% | +23.8% |
| ROA (TTM)Return on assets | +5.3% | -4.7% | +8.2% | -19.8% | +10.0% |
| ROICReturn on invested capital | +9.1% | +2.3% | +13.9% | +3.7% | +20.1% |
| ROCEReturn on capital employed | +10.4% | +2.6% | +14.4% | +4.3% | +23.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 | 7 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.57x | 1.07x | 0.55x | 1.35x | 0.68x |
| Net DebtTotal debt minus cash | $946M | $4.0B | $1.8B | $3.4B | $25.9B |
| Cash & Equiv.Liquid assets | $98M | $257M | $409M | $532M | $9.6B |
| Total DebtShort + long-term debt | $1.0B | $4.2B | $2.2B | $4.0B | $35.5B |
| Interest CoverageEBIT ÷ Interest expense | 7.40x | 0.23x | 15.59x | -7.20x | 487.21x |
Total Returns (Dividends Reinvested)
PG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PG five years ago would be worth $12,042 today (with dividends reinvested), compared to $2,744 for COTY. Over the past 12 months, CHD leads with a +2.6% total return vs PRGO's -52.0%. The 3-year compound annual growth rate (CAGR) favors PG at 0.7% vs COTY's -41.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.2% | -20.6% | +13.4% | -13.6% | +4.8% |
| 1-Year ReturnPast 12 months | -39.6% | -48.8% | +2.6% | -52.0% | -5.0% |
| 3-Year ReturnCumulative with dividends | -11.7% | -79.6% | +0.2% | -58.1% | +2.1% |
| 5-Year ReturnCumulative with dividends | +12.2% | -72.6% | +10.6% | -60.3% | +20.4% |
| 10-Year ReturnCumulative with dividends | -7.3% | -83.1% | +112.6% | -77.7% | +119.7% |
| CAGR (3Y)Annualised 3-year return | -4.1% | -41.1% | +0.1% | -25.2% | +0.7% |
Risk & Volatility
Evenly matched — CHD and PG each lead in 1 of 2 comparable metrics.
Risk & Volatility
PG is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than PRGO's 1.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.1% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.43x | 1.13x | 0.15x | 1.21x | 0.13x |
| 52-Week HighHighest price in past year | $89.37 | $5.34 | $106.04 | $28.44 | $170.99 |
| 52-Week LowLowest price in past year | $51.24 | $1.96 | $81.33 | $9.23 | $137.62 |
| % of 52W HighCurrent price vs 52-week peak | +58.8% | +46.3% | +88.1% | +41.2% | +85.6% |
| RSI (14)Momentum oscillator 0–100 | 37.9 | 57.9 | 45.7 | 53.1 | 49.6 |
| Avg Volume (50D)Average daily shares traded | 483K | 7.9M | 1.8M | 3.3M | 7.1M |
Analyst Outlook
Evenly matched — PRGO and PG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PBH as "Buy", COTY as "Hold", CHD as "Buy", PRGO as "Hold", PG as "Buy". Consensus price targets imply 209.1% upside for PRGO (target: $36) vs 10.6% for PG (target: $162). For income investors, PRGO offers the higher dividend yield at 9.82% vs COTY's 0.62%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $66.00 | $3.90 | $103.80 | $36.20 | $161.88 |
| # AnalystsCovering analysts | 17 | 33 | 34 | 36 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | +1.3% | +9.8% | +2.7% |
| Dividend StreakConsecutive years of raises | — | 1 | 23 | 10 | 36 |
| Dividend / ShareAnnual DPS | — | $0.02 | $1.18 | $1.15 | $4.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | 0.0% | +4.1% | 0.0% | +1.9% |
PG leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). PBH leads in 1 (Income & Cash Flow). 2 tied.
PBH vs COTY vs CHD vs PRGO vs PG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PBH or COTY or CHD or PRGO or PG a better buy right now?
For growth investors, Church & Dwight Co.
, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -3. 7% for Coty Inc. (COTY). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 2x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PBH or COTY or CHD or PRGO or PG?
On trailing P/E, Prestige Consumer Healthcare Inc.
(PBH) is the cheapest at 12. 2x versus Church & Dwight Co. , Inc. at 30. 9x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Prestige Consumer Healthcare Inc. wins at 1. 28x versus The Procter & Gamble Company's 3. 80x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PBH or COTY or CHD or PRGO or PG?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +20.
4%, compared to -72. 6% for Coty Inc. (COTY). Over 10 years, the gap is even starker: PG returned +119. 7% versus COTY's -83. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PBH or COTY or CHD or PRGO or PG?
By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.
13β versus Perrigo Company plc's 1. 21β — meaning PRGO is approximately 806% more volatile than PG relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.
05Which is growing faster — PBH or COTY or CHD or PRGO or PG?
By revenue growth (latest reported year), Church & Dwight Co.
, Inc. (CHD) is pulling ahead at 1. 6% versus -3. 7% for Coty Inc. (COTY). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PBH or COTY or CHD or PRGO or PG?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 4. 1% for COTY. At the gross margin level — before operating expenses — COTY leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PBH or COTY or CHD or PRGO or PG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Prestige Consumer Healthcare Inc. (PBH) is the more undervalued stock at a PEG of 1. 28x versus The Procter & Gamble Company's 3. 80x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Perrigo Company plc (PRGO) trades at 5. 5x forward P/E versus 24. 9x for Church & Dwight Co. , Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 209. 1% to $36. 20.
08Which pays a better dividend — PBH or COTY or CHD or PRGO or PG?
In this comparison, PRGO (9.
8% yield), PG (2. 7% yield), CHD (1. 3% yield), COTY (0. 6% yield) pay a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.
09Is PBH or COTY or CHD or PRGO or PG better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
13), 2. 7% yield, +119. 7% 10Y return). Both have compounded well over 10 years (PG: +119. 7%, PRGO: -77. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PBH and COTY and CHD and PRGO and PG?
These companies operate in different sectors (PBH (Healthcare) and COTY (Consumer Defensive) and CHD (Consumer Defensive) and PRGO (Healthcare) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PBH is a small-cap deep-value stock; COTY is a small-cap quality compounder stock; CHD is a mid-cap quality compounder stock; PRGO is a small-cap income-oriented stock; PG is a large-cap quality compounder stock. COTY, CHD, PRGO, PG pay a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.